Importantly, CIC‐Gal NMs protect cisplatin from GSH‐mediated detoxification, while promoting CD8+ T cell infiltration, inhibiting the proliferation and migration of MDSCs, and extending the survival of tumor‐bearing mice by >40 d. Here, CD8A is linked to neoplasm.